Valeric acid hydrazide

CAS : 38291-82-6

Ref. 3D-FV11825

Informations sur le produit

• Nom: Valeric acid hydrazide
• Synonymes: NSC 216079, NSC 523267, Pentanehydrazide, Pentanoic acid hydrazide, Pentanoic hydrazide, Pentanoyl hydrazide, Valeric hydrazide, Valerylhydrazine

Description

Valeric acid hydrazide (VAH) is a monoclonal antibody that binds to the receptor molecule. The binding of VAH to the receptor molecule leads to a change in the reaction mechanism and prevents the initiation of an immune response. This drug has been shown to have therapeutic properties in a number of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, by blocking the production of TNF-α and other inflammatory cytokines. Valeric acid hydrazide also shows biological properties against cancerous cells. It inhibits the growth factor activity, which is believed to be responsible for tumor formation and growth. This agent may also inhibit angiogenesis by preventing endothelial cell proliferation and migration.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 116.16 g/mol
• Formule: C₅H₁₂N₂O
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C5H12N2O/c1-2-3-4-5(8)7-6/h2-4,6H2,1H3,(H,7,8)
• Code InChI: InChIKey=PJBQYCIDGYKEMN-UHFFFAOYSA-N
• SMILES: CCCCC(=O)NN